Twitter Beğeni Hilesi

🚨📢We are hiring - come & join us! Looking for a bioinformatician interested in translational research - come work with us!😁 Manchester Cancer Research Centre Division of Cancer Sciences RTphysics Manchester ESTRO 👇🏽 jobs.manchester.ac.uk/Job/JobDetail?…

📣 As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022 Check out this new #originalresearch in BMJ Oncology: bmjoncology.bmj.com/content/3/1/e0… #OncoAlert @oncoalert

This editorial describes the approval history and regulatory implications of ibrutinib’s withdrawal from the US market. Read it on BMJ Oncology now: bmjoncology.bmj.com/content/3/1/e0…

This study shows that major osteoporotic fracture risk increases after immune checkpoint inhibitor initiation. bmjoncology.bmj.com/content/3/1/e0…

Looking forward to welcoming you again at #PROSCA24 #BLADDR24 #RENALC24 in Vienna OncoAlert 🙏 🗓️Check out our programme and register 👉 bit.ly/4cY6wA1 🥇Will be a great edition this year with amazing faculty & 1st edition of RENALC!

Super interesting comparative research published today in BMJ Oncology on the impact of COVID and Brexit in the UK Dr Mark Lythgoe

📣 Unlocking the predictive power of imaging biomarkers: predicting immune checkpoint therapy response in non-small cell lung cancer through baseline tumour vessel perfusions Read more in this new editorial: bmjoncology.bmj.com/content/3/1/e0… #OncoAlert OncoAlert

Great to have the opportunity to work with #SuraiyaDubash #MountVernonCancerCentre East and North Hertfordshire NHS Trust on this editorial BMJ Oncology !!!

Really important and been saying this for many years so good to see other sources supporting. Extent of debulking prognostic but not therapeutic nor practiced in other cancers. Pts in BC2001 with biopsy only did no differently to those with resections

Thanks for highlighting our review👇🏽 Interesting exploration of the interaction of #radionuclides #immuneTME & #prostatecancer Manchester Cancer Research Centre Division of Cancer Sciences ProstateUK Profs

.Cancer and Aging Research Group (CARG) #GeriOnc tool recommended in screening older patients having chemotherapy, but the National Oncology Trainees Research Collaborative TOASTIE study showed no predictive ability in a UK population. It is time to stop looking for shortcuts? Our BMJ Oncology editorial here #gerionc bmjoncology.bmj.com/content/3/1/e0…

Delighted to see the National Oncology Trainees Research Collaborative UK prospective 'Tolerance Of Anti-cancer Systemic Therapy In the Elderly: The 𝐓𝐎𝐀𝐒𝐓𝐈𝐄 study' published in BMJ Oncology. bmjoncology.bmj.com/content/3/1/e0… Helen Dearden Michael Rowe Sally Martin SIOG Young SIOG SIOGNAH UoD Medicine 1/9

We stand on the shoulders of giants 💪💪 effort (30 years of follow up) of 🏴󠁧󠁢󠁳󠁣󠁴󠁿 #breastcancer #radonc trial Why does this long follow up matter? Because it reassures that the endpoints of interest all occur in first decade. thelancet.com/journals/lanon…

Systematic review found that 43% of randomized clinical trials of anticancer treatment in the adjuvant or neoadjuvant context failed to present any assessable postrecurrence treatment data. ja.ma/3YMKZGH

Still unsure where to submit your TOP research results ? TOP clinical trials ? 👉 #ESTRO25 in Vienna 👉 to be presented in special session featured by The Lancet Oncology and Radiotherapy & Oncology 👉 abstracts to be evaluated for simultaneous publication in these prestigious journals

Despite multiple guidelines, including ‘Choosing Wisely’, advocating against the use of PET-CT for surveillance of patients with cancer treated with curative intent, we see widespread PET-CT imaging. bmjoncology.bmj.com/content/3/1/e0…

Congratulations Cynthia Eccles 💙 - fantastic news! RTphysics Manchester Manchester Cancer Research Centre & Division of Cancer Sciences are very proud! Let's celebrate! 🥳🎉👏🏽

Online First: #Palliative #radiotherapy versus best supportive care in patients with painful #hepaticcancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study #radonc thelancet.com/journals/lanon…

It's #BUG24 - The 21st annual meeting here in sunny Belfast! Exciting to come together & talk all things #uroOncology! Prof Joe O'Sullivan Robert Huddart💙 Jon Aning Julia Murray UroToday.com The Royal College of Radiologists Manchester Cancer Research Centre Alison Tree 💙 💙alison birtle Martin Swinton Nick James

Not only do low- and middle-income countries account for a staggering 57% of cancer cases, but they also experience higher mortality rates, contributing to nearly two-thirds of cancer deaths globally. bmjoncology.bmj.com/content/3/1/e0…